UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The LL-100 panel: 100 cell lines for blood cancer studies

Scientific reports, 2019-06, Vol.9 (1), p.8218-8218, Article 8218

2019

Volltextzugriff (PDF)

The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research

International journal of molecular sciences, 2020-08, Vol.21 (16), p.5800

2020

Volltextzugriff (PDF)

Inhibition of MCL1 induces apoptosis in anaplastic large cell lymphoma and in primary effusion lymphoma

Scientific reports, 2022-01, Vol.12 (1), p.1085-1085, Article 1085

2022

Volltextzugriff (PDF)

Loss of KDM6A confers drug resistance in acute myeloid leukemia

Leukemia, 2020-01, Vol.34 (1), p.50-62

2020

Volltextzugriff (PDF)

Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression

Current issues in molecular biology, 2021-11, Vol.43 (3), p.2147-2156

2021

Volltextzugriff (PDF)

Mutation of the Wilms’ Tumor 1 Gene Is a Poor Prognostic Factor Associated With Chemotherapy Resistance in Normal Karyotype Acute Myeloid Leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5429-5435

2008

Volltextzugriff (PDF)

Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia

Current oncology (Toronto), 2021-05, Vol.28 (3), p.1790-1794

2021

Volltextzugriff (PDF)

SLAMF7 in Primary Effusion Lymphoma, Target for Individualized Therapy?

Blood, 2018-11, Vol.132 (Supplement 1), p.5300-5300

2018

Volltextzugriff (PDF)

BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance

Journal of hematology and oncology, 2011-02, Vol.4 (1), p.6-6, Article 6

2011

Volltextzugriff (PDF)

Inhibition of PI3K/mTOR overcomes nilotinib resistance in BCR-ABL1 positive leukemia cells through translational down-regulation of MDM2

PloS one, 2013-12, Vol.8 (12), p.e83510

2013

Volltextzugriff (PDF)

High accuracy mutation detection in leukemia on a selected panel of cancer genes

PloS one, 2012-06, Vol.7 (6), p.e38463-e38463

2012

Volltextzugriff (PDF)

CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes

Clinical cancer research, 2009-04, Vol.15 (7), p.2238-2247

2009

Volltextzugriff (PDF)

DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4)

BMC cancer, 2012-01, Vol.12 (1), p.19-19, Article 19

2012

Volltextzugriff (PDF)

Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma

Biomedicines, 2022-08, Vol.10 (8), p.2038

2022

Volltextzugriff (PDF)

Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing

PloS one, 2016-12, Vol.11 (12), p.e0167599-e0167599

2016

Volltextzugriff (PDF)

t(8;9)(p22;p24)/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5

PloS one, 2013-01, Vol.8 (1), p.e53767

2013

Volltextzugriff (PDF)

There is a Scientific Need for the Right Leukemia‐Lymphoma Cell Lines

HemaSphere, 2019-12, Vol.3 (6), p.e315-n/a

2019

Volltextzugriff (PDF)

Peripheral T-cell lymphoma cell line T8ML-1 highlights conspicuous targeting of PVRL2 by t(14;19)(q11.2;q13.3)

Haematologica (Roma), 2017-09, Vol.102 (9), p.e356-e359

2017

Volltextzugriff (PDF)

Ectopic expression of homeobox gene NKX2-1 in diffuse large B-cell lymphoma is mediated by aberrant chromatin modifications

PloS one, 2013-04, Vol.8 (4), p.e61447

2013

Volltextzugriff (PDF)

BCL6--regulated by AhR/ARNT and wild-type MEF2B--drives expression of germinal center markers MYBL1 and LMO2

Haematologica (Roma), 2015-06, Vol.100 (6), p.801-809

2015

Volltextzugriff (PDF)

Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma

BMC cancer, 2010-09, Vol.10 (1), p.517-517

2010

Volltextzugriff (PDF)

The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia

Blood, 2004-04, Vol.103 (7), p.2802-2805

2004

Volltextzugriff (PDF)

Correction: Ectopic Expression of Homeobox Gene NKX2-1 in Diffuse Large B-Cell Lymphoma Is Mediated by Aberrant Chromatin Modifications

PloS one, 2013-06, Vol.8 (6)

2013

Volltextzugriff (PDF)

Epigenetic Modifier Mutations in the LL-100 Panel

Blood, 2018-11, Vol.132 (Supplement 1), p.5271-5271

2018

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(116)

Sprache

Englisch
(116)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Humans
(58)
Life Sciences & Biomedicine
(58)
Hematology
(38)
Oncology
(36)
Cell Line, Tumor
(28)
Biological And Medical Sciences
(23)
Leukemia
(23)
Cell Lines
(19)
Mutation
(18)
Medical Sciences
(17)
Tumor Cells, Cultured
(13)
Apoptosis
(12)
Lymphoma
(12)
Cell Division - Drug Effects
(10)
Gene Expression
(10)
Hematologic And Hematopoietic Diseases
(10)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(10)
Cell Biology
(9)
Female
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The LL-100 panel: 100 cell lines for blood cancer studies

The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research

Inhibition of MCL1 induces apoptosis in anaplastic large cell lymphoma and in primary effusion lymphoma

Loss of KDM6A confers drug resistance in acute myeloid leukemia

Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression

Mutation of the Wilms’ Tumor 1 Gene Is a Poor Prognostic Factor Associated With Chemotherapy Resistance in Normal Karyotype Acute Myeloid Leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party

Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia

SLAMF7 in Primary Effusion Lymphoma, Target for Individualized Therapy?

BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance

Inhibition of PI3K/mTOR overcomes nilotinib resistance in BCR-ABL1 positive leukemia cells through translational down-regulation of MDM2

High accuracy mutation detection in leukemia on a selected panel of cancer genes

CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes

DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4)

Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma

Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing

t(8;9)(p22;p24)/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5

There is a Scientific Need for the Right Leukemia‐Lymphoma Cell Lines

Epigenetically induced ectopic expression of UNCX impairs the proliferation and differentiation of myeloid cells

Peripheral T-cell lymphoma cell line T8ML-1 highlights conspicuous targeting of PVRL2 by t(14;19)(q11.2;q13.3)

Ectopic expression of homeobox gene NKX2-1 in diffuse large B-cell lymphoma is mediated by aberrant chromatin modifications

BCL6--regulated by AhR/ARNT and wild-type MEF2B--drives expression of germinal center markers MYBL1 and LMO2

Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma

The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia

Correction: Ectopic Expression of Homeobox Gene NKX2-1 in Diffuse Large B-Cell Lymphoma Is Mediated by Aberrant Chromatin Modifications

Epigenetic Modifier Mutations in the LL-100 Panel

Suchergebnisse filtern